Table 1.
Gender | Age (Years) | Disease Duration (Years) | Bulbar vs. Nonbulbar | Average Bulbar ALSFRS-R Score* | Disease Progression | |
---|---|---|---|---|---|---|
ALS case | ||||||
1 | Female | 46 | 15.5 | Nonbulbar | Unknown | Unknown |
2 | Female | 57 | 3 | Bulbar | 0 | Moderate |
3 | Female | 58 | 2.8 | Nonbulbar | 1 | Fast |
4 | Male | 62 | 6 | Nonbulbar | 2.7 | Slow |
5 | Female | 66 | 5 | Bulbar | 1 | Moderate |
6 | Female | 67 | 2.8 | Bulbar | 0.3 | Moderate |
7 | Male | 70 | 18 | Nonbulbar | 2 | Slow |
8 | Female | 71 | 23 | Nonbulbar | 3.7 | Slow |
9 | Male | 74 | 1.1 | Bulbar | 0.7 | Fast |
10 | Male | 75 | 4 | Bulbar | 0 | Moderate |
Control case | Gender | Age (Years) | Cause of Death | |||
1 | Female | 50 | Asthma | |||
2 | Female | 65 | Pneumonia | |||
3 | Male | 65 | Myocardial infarction | |||
4 | Female | 67 | Liver failure | |||
5 | Male | 69 | Respiratory failure | |||
6 | Male | 69 | Subdural hemorrhage | |||
7 | Female | 73 | Chronic obstructive pulmonary disease | |||
8 | Male | 75 | Cancer | |||
9 | Female | 77 | Myocardial infarction | |||
10 | Male | 92 | Myelodysplastic syndrome |
Each patient received a score from 0 (complete disability) to 4 (normal function) for speech, salivation, and swallowing. The average of these three scores is reported here.